This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry.It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides a…
This book invites clinicians to take a fresh look at the routine physical examination by outlining in detail how they can adapt a more efficient, regional approach to the exam activity. By adopting the systematic sequence and focus provided in this novel title, clinicians can offer a more modern physical examination, one that may prove more productive than the methods taught in the pre-imaging era. The Physical Exam: An Innovative Approach in the Age of Imaging offers a unique, step-by-step seq…
Schizophrenia: the lay public knows a general picture formed from popular culture, familiar legend, and, often, family history. The professional community knows a clinical profile gleaned from decades of scientific theory and findings. But recently a growing body of literature has begun to suggest not only that the diagnosis of schizophrenia is misleading, but that the concept of the disease itself is outmoded. Schizophrenia is a Misdiagnosis makes a persuasive, well-documented argument for the…